MPCI Share Price Performance
ج.م153.68
117.20 (321.27%)
Price ج.م153.68
Share Priceج.م153.68
Memphis Pharmaceuticals & Chemical Industries Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 8 Fair Values set on narratives written by author
MPCI Community Narratives
There are no narratives available yet.
Recent MPCI News & Updates
Memphis Pharmaceuticals & Chemical Industries Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- 22.21
- Gross Margin
- 45.10%
- Net Profit Margin
- 33.51%
- Debt/Equity Ratio
- 12.3%
Memphis Pharmaceuticals & Chemical Industries Competitors
Snowflake Analysis
About MPCI
- Founded
- 1940
- Employees
- n/a
- CEO
- WebsiteView website
Memphis Pharmaceuticals & Chemical Industries, a drug holding company, produces and sells pharmaceutical products for human and veterinary use in Egypt and internationally. The company offers human health products in various therapeutic areas, including anti-infective, CNS, dermatological, cardio vascular system, corticosteroid, vitamins and minerals, musculo-skeletal system, analgesic and antipyretic, respiratory system, genitourinary system, alimentary tract and metabolism, antihistaminic, antiparasites, and hormones. It also provides animal health products in powder form, as well as in oral and injectable solution forms. The company was founded in 1940 and is based in Cairo, Egypt. Memphis Pharmaceuticals & Chemical Industries is a subsidiary of HoldiPharma.
Market Insight
Rare earths may be a sliver of the global metals market, but they punch far above their weight. These obscure elements are the invisible wiring of modern life.
Continue reading
Egyptian Market Performance
- 7 Days: 3.1%
- 3 Months: 8.4%
- 1 Year: 14.1%
- Year to Date: 17.7%
Over the last 7 days, the market has risen 2.2%, driven by gains of 2.5% in the Financials sector. As for the past 12 months, the market is up 13%. Earnings are forecast to grow by 13% annually. Market details ›